{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-066953","form_type":"8-K","ticker":"TMDX","cik":"0001756262","company_name":"TransMedics Group, Inc.","filed_at":"2026-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.085350+00:00","generated_at":"2026-05-16T00:51:09.216703+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"TransMedics Q4 revenue $160.8M (+32% YoY); net income $105.4M includes $83.8M tax benefit","bullets":["Q4 revenue $160.8M (+32% YoY); full-year revenue $605.5M (+37% YoY).","Net income $105.4M in Q4 ($2.62 diluted EPS); full-year net income $190.3M ($4.87 diluted EPS). Both include one-time tax benefit from valuation allowance release.","U.S. OCS cases 5,139 in FY2025 (+38% YoY); owned 22 aircraft as of Dec 31, 2025.","FY2026 revenue guidance $727M-$757M, representing 20% to 25% growth over FY2025.","Appointed Giovanni Cecere as CCO, Amanda Sorrento as SVP HR, Matthew Forsyth as SVP GC; FDA approved OCS ENHANCE Heart and DENOVO Lung trials."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-066953","json":"https://secwatch.observer/filing/0001193125-26-066953.json","markdown":"https://secwatch.observer/filing/0001193125-26-066953.md","text":"https://secwatch.observer/filing/0001193125-26-066953.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1756262/000119312526066953/0001193125-26-066953-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1756262/000119312526066953/tmdx-20260224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:51:09.216703+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}